galantamine and Cardiac Toxicity

galantamine has been researched along with Cardiac Toxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Coenen, A; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Leitz, P; Niehues, P	1

Other Studies

1 other study(ies) available for galantamine and Cardiac Toxicity

Article	Year
Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model. Cardiovascular toxicology, 2020, Volume: 20, Issue:2 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotoxicity; Cholinesterase Inhibitors; Donepezil; Galantamine; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Rabbits; Refractory Period, Electrophysiological; Risk Assessment; Rivastigmine; Time Factors	2020

Article

Year

Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.

Cardiovascular toxicology, 2020, Volume: 20, Issue:2

Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotoxicity; Cholinesterase Inhibitors; Donepezil; Galantamine; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Rabbits; Refractory Period, Electrophysiological; Risk Assessment; Rivastigmine; Time Factors

2020